Patricia Ann Duffy

Array ( [id] => 1096701 [patent_doc_number] => 06822071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease' [patent_app_type] => B1 [patent_app_number] => 09/438185 [patent_app_country] => US [patent_app_date] => 1999-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28220 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/822/06822071.pdf [firstpage_image] =>[orig_patent_app_number] => 09438185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517117 [patent_doc_number] => 06500674 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications' [patent_app_type] => B1 [patent_app_number] => 09/432285 [patent_app_country] => US [patent_app_date] => 1999-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 12431 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500674.pdf [firstpage_image] =>[orig_patent_app_number] => 09432285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813524 [patent_doc_number] => 20030073074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'DIAGNOSTIC ASSAY FOR ALZHEIMER\'S DISEASE: ASSESSMENT OF AB ABNORMALITIES' [patent_app_type] => new [patent_app_number] => 09/425956 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21421 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073074.pdf [firstpage_image] =>[orig_patent_app_number] => 09425956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523495 [patent_doc_number] => 06352843 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'YsxC from Staphylococcus aureus ' [patent_app_type] => B1 [patent_app_number] => 09/412779 [patent_app_country] => US [patent_app_date] => 1999-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12828 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352843.pdf [firstpage_image] =>[orig_patent_app_number] => 09412779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331892 [patent_doc_number] => 06596546 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Detection of antibodies to bacterial antigens by fluorescence polarization' [patent_app_type] => B1 [patent_app_number] => 09/400798 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6427 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596546.pdf [firstpage_image] =>[orig_patent_app_number] => 09400798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4300048 [patent_doc_number] => 06251617 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Glycine transporter' [patent_app_type] => 1 [patent_app_number] => 9/396177 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10894 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251617.pdf [firstpage_image] =>[orig_patent_app_number] => 396177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4365263 [patent_doc_number] => 06274380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Cacnglike3 polynucleotides and expression systems' [patent_app_type] => 1 [patent_app_number] => 9/392014 [patent_app_country] => US [patent_app_date] => 1999-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10490 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274380.pdf [firstpage_image] =>[orig_patent_app_number] => 392014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6176254 [patent_doc_number] => 20020155553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'HUMAN VESICLE BINDING PROTEIN' [patent_app_type] => new [patent_app_number] => 09/360540 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17091 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155553.pdf [firstpage_image] =>[orig_patent_app_number] => 09360540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1552567 [patent_doc_number] => 06348197 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'In ovo vaccination against Newcastle Disease' [patent_app_type] => B1 [patent_app_number] => 09/319481 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1317 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348197.pdf [firstpage_image] =>[orig_patent_app_number] => 09319481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278913 [patent_doc_number] => 06641815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Sequestrin' [patent_app_type] => B2 [patent_app_number] => 09/351794 [patent_app_country] => US [patent_app_date] => 1999-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12761 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641815.pdf [firstpage_image] =>[orig_patent_app_number] => 09351794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786379 [patent_doc_number] => 20020160009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'CANDIDA ALBICANS PHOSHOMANNAN COMPLEX AS A VACCINE' [patent_app_type] => new [patent_app_number] => 09/351630 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20339 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160009.pdf [firstpage_image] =>[orig_patent_app_number] => 09351630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374972 [patent_doc_number] => 20020119161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'METHOD OF SEPARATING PROTECTIVE COMPONENTS OF BORDETELLA PERTUSSIS' [patent_app_type] => new [patent_app_number] => 09/349712 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9135 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119161.pdf [firstpage_image] =>[orig_patent_app_number] => 09349712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407628 [patent_doc_number] => 06228627 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Mur A-1 from Streptococcus pneumoniae' [patent_app_type] => 1 [patent_app_number] => 9/349851 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15935 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228627.pdf [firstpage_image] =>[orig_patent_app_number] => 349851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408482 [patent_doc_number] => 06232437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.' [patent_app_type] => 1 [patent_app_number] => 9/348952 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10991 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232437.pdf [firstpage_image] =>[orig_patent_app_number] => 348952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353352 [patent_doc_number] => 06200779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Polynucleotides, vectors and host cells encoding LicB from streptococcus pneumonial' [patent_app_type] => 1 [patent_app_number] => 9/348116 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14465 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200779.pdf [firstpage_image] =>[orig_patent_app_number] => 348116 [rel_patent_id] =>[rel_patent_doc_number] =>)